Home » Stocks » CURR

CURE Pharmaceutical Holding Corp. (CURR)

Stock Price: $0.8100 USD 0.0340 (4.38%)
Updated Apr 16, 2021 2:51 PM EDT - Market closed
Market Cap 48.21M
Revenue (ttm) 2.05M
Net Income (ttm) -30.62M
Shares Out 59.52M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $0.8100
Previous Close $0.7760
Change ($) 0.0340
Change (%) 4.38%
Day's Open 0.7700
Day's Range 0.7700 - 0.8999
Day's Volume 98,269
52-Week Range 0.7300 - 2.6500

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial and operating results for th...

2 weeks ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

3 weeks ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

1 month ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it h...

1 month ago - Business Wire

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development ...

1 month ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness pro...

2 months ago - Business Wire

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D insufficiency. In response, Sera...

2 months ago - Business Wire

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today they ...

2 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health...

2 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp (“CURE” or the “Company”) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the ...

3 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and dru...

4 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug ...

5 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Closes $10 Million Financing

5 months ago - Business Wire

LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging the status quo of the health and wellness sector by bringing inn...

5 months ago - Business Wire

OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October.

6 months ago - Business Wire

- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT - 

7 months ago - GlobeNewsWire

SHERMAN OAKS, Calif.--(BUSINESS WIRE)-- #Beauty--Sera Labs, a Leader in the CBD Industry to be acquired by CURE Pharmaceutical in a $20 Million Transaction

8 months ago - Business Wire

Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology Significantly higher serum concentration and absorption Showcases CUREform™ encaps...

9 months ago - GlobeNewsWire

OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facil...

9 months ago - GlobeNewsWire

- Jonathan Berlent Appointed to Newly Created Role - - Jonathan Berlent Appointed to Newly Created Role -

10 months ago - GlobeNewsWire

OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announ...

10 months ago - GlobeNewsWire

About CURR

CURE Pharmaceutical Holding Corp., together with its subsidiaries, operates as an integrated drug delivery and development company in the United States and internationally. It focuses on the development and manufacture of drug formulation and drug delivery technologies in novel dosage forms to enhance drug efficacy, safety, and patient adherence. The company operates through two business segments: Cure and Sera Labs. It offers pharmaceutical and wellness products, including CUREfilm Blue, a sildenafil oral thin film for the treatment of erectil... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
2011
Stock Exchange
OTCMKTS
Ticker Symbol
CURR
Full Company Profile

Financial Performance

In 2020, CURR's revenue was $2.05 million, an increase of 229.21% compared to the previous year's $623,000. Losses were -$30.62 million, 43.3% more than in 2019.

Financial Statements